NCT02104843View on ClinicalTrials.gov

Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

Daclatasvir, Asunaprevir and BMS-791325 FDC

DRUG

BMS-791325

DRUG

Rosuvastatin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY